MMPP
MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
Product Specifications
CAS Number
1895957-18-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
270.32
Molecular Formula
C17H18O3
Notes
Research use only, not for human use.
Receptor
STAT | VEGFR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
